Genedata, the Swiss-based computational solutions provider, announces a major research informatics solution deal with the global biopharmaceutical company UCB. UCB researchers in the UK and Belgium use the Genedata Phylosopher® platform combined with the Genedata Expressionist® platform to support their drug discovery efforts in the fields of central nervous system disorders, allergy/respiratory diseases, immune and inflammatory disorders and oncology.
